GlassScriptPhysician profile
Ramni Khattar
NPI 1225423619
$2,293.76
in general payments reported to CMS, 2019-2025
18 companies · $543 in 2025
The $543 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $202 · 2022: $365 · 2023: $221 · 2024: $962 · 2025: $543.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,706 · Education: $20.34.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,706.17 |
| Education | $20.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,014.37 | 2022-2025 | Ofev, Jascayd, Stiolto Respimat |
| United Therapeutics Corporation | $243.85 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $213.61 | 2024-2025 | Airsupra, Breztri, Fasenra |
| Glaxosmithkline, LLC. | $166.35 | 2025 | Nucala, Trelegy Ellipta, Arexvy |
| Olympus America INC. | $152.58 | 2021 | |
| Inari Medical, INC. | $151.76 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Grifols USA, LLC | $66.10 | 2024 | Xembify, Prolastin-C Liquid |
| Veran Medical Technologies, INC. | $49.60 | 2021 | |
| Baxter Healthcare | $45.63 | 2024 | Hillrom - Vest System Model 105 Home Care |
| Verona Pharma, INC. | $31.96 | 2025 | Ohtuvayre |
| E.R. Squibb & Sons, L.L.C. | $23.92 | 2024 | Eliquis |
| Inspire Medical Systems, INC. | $22.15 | 2023 | Inspire |
| Mallinckrodt Hospital Products INC. | $21.35 | 2024 | Acthar |
| Recordati_rare_diseases_inc. | $20.06 | 2025 | Isturisa |
| Phathom Pharmaceuticals, INC. | $18.62 | 2024 | Voquezna |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $17.81 | 2024 | Cabenuva |
| Breas Medical, INC. | $17.59 | 2024 | Vivo 45 Ls |
| Celltrion USA INC. | $16.45 | 2025 | Vegzelma |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ramni Khattar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.